“If you have expression of a specific target over a cutpoint, we want to be able to predict what clinical response would be.” First, clinicians need to know which biomarkers, or combinations ...

[4] This review is centered on PC biomarker development accomplished through microarray-based mRNA and miRNA gene expression profiling.

Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients. The new ...

More information: Marina Bluma et al, Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics, eBioMedicine ...

Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...